Personalized Medicine and the Treatment of Hypertension

被引:27
|
作者
Melville, Sarah [1 ,2 ]
Byrd, James Brian [3 ]
机构
[1] St Johns Hosp, CardioVasc Res New Brunswick, St John, NB, Canada
[2] IMPART Investigator Team Canada, St John, NB, Canada
[3] Univ Michigan, Sch Med, Dept Internal Med, Div Cardiovasc Med, 5570 CMSRB 2,1150 West Med Ctr Dr,SPC 5678, Ann Arbor, MI 48109 USA
关键词
Personalized medicine; Population health; Blood pressure; Hypertension; Resistant hypertension; Primary aldosteronism; RESISTANT HYPERTENSION; BLOOD-PRESSURE; ANTIHYPERTENSIVE MEDICATION; RENAL DENERVATION; MANAGEMENT; TRIAL; SPIRONOLACTONE; STRATEGIES; DIAGNOSIS; SYSTEM;
D O I
10.1007/s11906-019-0921-3
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose of Review The purpose of this review is to discuss the implications of personalized medicine for the treatment of hypertension, including resistant hypertension. Recent Findings We suggest a framework for the personalized treatment of hypertension based on the concept of a trade-off between simplicity and personalization. This framework is based on treatment strategies classified as low, medium, or high information burden personalization approaches. The extent to which a higher information burden is justified depends on the clinical scenario, particularly the ease with which the blood pressure can be controlled. Summary A one-size-fits-many treatment strategy for hypertension is efficacious for most people; however, a more personalized approach could be useful in patients with subtypes of hypertension that do not respond as expected to treatment. Clinicians seeing patients with unusual hypertension phenotypes should be familiar with emerging trends in personalized treatment of hypertension.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Personalized Medicine and the Treatment of Hypertension
    Sarah Melville
    James Brian Byrd
    [J]. Current Hypertension Reports, 2019, 21
  • [2] Personalized medicine and treatment approaches in hypertension: current perspectives
    Byrd, James Brian
    [J]. INTEGRATED BLOOD PRESSURE CONTROL, 2016, 9 : 59 - 66
  • [3] Personalized medicine in pulmonary hypertension
    Milger-Kneidinger, K.
    [J]. PNEUMOLOGE, 2019, 16 (02): : 76 - 87
  • [4] Pharmacogenomic approaches targeting on the personalized medicine for hypertension
    Rakugi, Hiromi
    Kamide, Kei
    [J]. ENDOCRINE JOURNAL, 2010, 57 : S275 - S275
  • [5] PHARMACOGENOMICS AND THE CONCEPT OF PERSONALIZED MEDICINE FOR THE MANAGEMENT OF HYPERTENSION
    Ashiq, Kanwal
    Ashiq, Sana
    Mustafa, Nosheen
    [J]. PAKISTAN HEART JOURNAL, 2023, 56 (02): : 188 - 190
  • [6] Personalized medicine in COPD treatment
    Shen, Ning
    He, Bei
    [J]. CURRENT PULMONOLOGY REPORTS, 2014, 3 (03) : 133 - 139
  • [7] Personalized medicine in the treatment of acromegaly
    Kasuki, Leandro
    Wildemberg, Luiz Eduardo
    Gadelha, Monica R.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 178 (03) : R89 - R100
  • [8] PHARMACOGENOMICS OF HYPERTENSION: A NEW APPROACH FOR A PERSONALIZED MEDICINE
    Maggioni, C.
    Lanzani, C.
    Citterio, L.
    Catena, C.
    Bigazzi, R.
    Delli Carpini, S.
    Manunta, P.
    [J]. JOURNAL OF HYPERTENSION, 2019, 37 : E216 - E216
  • [9] Personalized medicine in COPD treatment
    Ning Shen
    Bei He
    [J]. Current Respiratory Care Reports, 2014, 3 (3): : 133 - 139
  • [10] Personalized medicine for HCV treatment
    Yu, M. -L.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S3 - S4